Related Parties

12 Months Ended

Dec. 31, 2015

Related Party Transactions [Abstract]

Related Parties

12. Related parties:

Dr. August J. Troendle, an officer and director of Medpace, which provides clinical development services to the Company, is a beneficial owner of more than 5% of the Company’s common shares. The Company incurred $922 of clinical development service fees under its priority access agreement and a master services agreement with Medpace for the year ended December 31, 2015 (2014 – nil, 2013 – nil). Additionally, the Company has recorded $2,314 of prepaid expenses as of December 31, 2015 (December 31, 2014 - nil) for future clinical development services under such agreements with Medpace.